½ÃÀ庸°í¼­
»óǰÄÚµå
1589792

¼¼°èÀÇ °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Epilepsy Monitoring Device Market by Product (Conventional Devices, Wearable Devices), End User (Clinics, Home Care Settings, Hospitals) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

°£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº 2023³â¿¡ 5¾ï 5,277¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 5¾ï 9,361¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.48%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 9¾ï 1,596¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

°£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ȯÀÚÀÇ ¹ßÀÛ È°µ¿À» °ËÃâ, ±â·Ï, ºÐ¼®ÇÏ°í °£ÁúÀÇ È¿À²ÀûÀÎ Áø´Ü ¹× °ü¸®¸¦ °¡´ÉÇÏ°Ô Çϵµ·Ï ¼³°èµÈ Àåºñ¸¦ Æ÷ÇÔÇÕ´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ¿¡´Â EEG ½Ã½ºÅÛ, ½º¸¶Æ® ¿öÄ¡¿Í °°Àº ¿þ¾î·¯ºí Àåºñ, ³ú Ȱµ¿À» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇϰí Àû½Ã¿¡ °æ°í ¹× µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â ÀÓº£µðµå Àåºñ µîÀÌ Æ÷ÇԵ˴ϴÙ. ±× Çʿ伺Àº ¹ßÀÛÀÇ ¿¹Ãø ºÒ°¡´É¼º ¹× ¿ÀÁø°ú °°Àº °úÁ¦¸¦ ÇØ°áÇϰí Ä¡·á °èȹ°ú ȯÀÚÀÇ QOLÀ» °³¼±Çϱâ À§ÇØ ¹ßÀÛÀ» Á¤È®ÇÏ°Ô ¸ð´ÏÅ͸µÇÏ´Â ¸Å¿ì Áß¿äÇÑ ÇÊ¿ä·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. ¿ëµµ´Â º´¿ø, ½Å°æ¼¾ÅÍ, ÀçÅà °£È£ ¹× ½Å°æ°ú ÀÇ»ç, °£º´ÀÎ, ȯÀÚ Àڽſ¡ ÀÇÇØ ÀÌ¿ëµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀº ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í °Ç°­ °ü¸® ÀÇ½Ä Áõ°¡¿Í ÇÔ²² ¹«¼± Åë½Å ¹× AI ÁÖµµ ºÐ¼®ÀÇ ±â¼úÀû Áøº¸¸¦ Æ÷ÇÔÇÕ´Ï´Ù. °Ô´Ù°¡, ÇコÄɾ À־ÀÇ IoTÀÇ ÅëÇÕ°ú, Àúħ½À¡¤ºñħ½À ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ »õ·Î¿î ±æÀ» ¿­°í ÀÖ½À´Ï´Ù. ½ÃÀå °³Ã´ ±âȸ´Â ¿ø°Ý ÀÇ·á ¼­ºñ½º È®´ë, º¸´Ù °³º°È­µÈ »ç¿ëÀÚ Ä£È­ÀûÀÎ Àåºñ °³¹ß, °í±Þ AI ¾Ë°í¸®ÁòÀ¸·Î Áø´Ü Á¤È®µµ¸¦ Çâ»ó½ÃŰ´Â µ¥ ÀÖ½À´Ï´Ù. ±â¾÷Àº µ¥ÀÌÅÍ °øÀ¯¸¦ À§ÇÑ Àü·«Àû ÆÄÆ®³Ê½ÊÀ» Çü¼ºÇϰí FDA ½ÂÀÎÀ» °¡¼ÓÈ­ÇÔÀ¸·Î½á ÀÚº»È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª °í°¡ÀÇ Àåºñ ºñ¿ë, ±ÔÁ¦ ¹®Á¦, µ¥ÀÌÅÍ ÇÁ¶óÀ̹ö½Ã¿¡ ´ëÇÑ ¿ì·Á µî°ú °°Àº Àå¾Ö°¡ Å« À庮ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ º¹ÀâÇÑ µ¥ÀÌÅ͸¦ ÇØ¼®ÇÏ´Â ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·µµ ¿©ÀüÈ÷ Àå¾Ö¹°ÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¹èÅ͸® ¼ö¸íÀÌ ±æ°í ¹ßÀÛ ¿¹Ãø°ú ºÐ·ùÀÇ Á¤¹Ðµµ°¡ ³ôÀº ÄÄÆÑÆ®ÇÑ ¿þ¾î·¯ºí ±â±âÀÇ Çõ½ÅÀ̳ª ¾ÈÀüÇÑ µ¥ÀÌÅÍ °ü¸®¸¦ À§ÇÑ ºí·ÏüÀÎÀÇ Å½±¸¿¡´Â °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ëÀÚ¿ÍÀÇ °øµ¿ ¿¬±¸¿Í ÀϰüµÈ Çǵå¹é ·çÇÁ´Â ¸Å¿ì Áß¿äÇÑ ÅëÂû·ÂÀ» Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ¸ç ±â¼ú Áøº¸°¡ ÇöÀúÇÏÁö¸¸ °æÀïÀº Ä¡¿­ÇÏ¸ç ±â¾÷Àº ¹ÎøÇÏ°í °í°´ ÁöÇâÀ» À¯ÁöÇØ¾ßÇÕ´Ï´Ù. Áß¿äÇÑ °ÍÀº ¾ö°ÝÇÑ µ¥ÀÌÅÍ º¸¾È ´ëÃ¥°ú Åõ¸íÇÑ È¯ÀÚ¿ÍÀÇ Ä¿¹Â´ÏÄÉÀ̼ÇÀ» ÅëÇØ ½Å·Ú¸¦ Á¶¼ºÇÏ´Â °ÍÀÌ ½ÃÀåÀÇ ÆòÆÇ°ú ¼ºÀåÀ» À¯ÁöÇϱâ À§ÇÑ ±âº»ÀÌ µÈ´Ù´Â °ÍÀÔ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 5¾ï 5,277¸¸ ´Þ·¯
¿¹Ãø³â(2024) 5¾ï 9,361¸¸ ´Þ·¯
¿¹Ãø³â(2030) 9¾ï 1,596¸¸ ´Þ·¯
CAGR(%) 7.48%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

°£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿Àû ÀÎ »óÈ£ ÀÛ¿ë¿¡ ÀÇÇØ º¯È­¸¦ °Þ°í ÀÖ½À´Ï´Ù. È­¿Í »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÏ´Â °Í ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°Í Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ½Å°æÁúȯÀÇ ¹ß»ý·ü°ú À¯º´·ü Áõ°¡
    • °£Áú ¸ð´ÏÅ͸µ ±â±âÀÇ Á¤±âÀûÀÎ ±â¼ú Çâ»ó
    • Á¤ºÎ·ÎºÎÅÍÀÇ ÅõÀÚ¿Í Áö¿ø Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • º¹ÀâÇÑ ÀýÂ÷¿Í ÀåºñÀÇ ³ôÀº ºñ¿ë
  • ½ÃÀå ±âȸ
    • ºñħ½À¼º ¹× Àúħ½À¼º ±â±â¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • ³ú ¸ð´ÏÅ͸µ ±â±âÀÇ Ä¡·á ¿ëµµÀÇ È®´ë
  • ½ÃÀåÀÇ °úÁ¦
    • Áõ»ó¿¡ ´ëÇÑ Àνİú ÈÆ·ÃÀ» ¹ÞÀº Àü¹®°¡ÀÇ ºÎÁ·

Porter's Five Forces: °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¹ýÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸ Á¦°øÇÕ´Ï´Ù.PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù., ¾ÕÀ» ³»´Ùº¸°í Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

°£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù.ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸± Çʿ䰡 ÀÖ½À´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡ µû¶ó °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

°£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇöÀå °­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ½Å°æÁúȯÀÇ ¹ß»ý·ü°ú À¯º´·ü Áõ°¡
      • °£Áú ¸ð´ÏÅ͸µ Àåºñ ±â¼úÀÇ Á¤±â ¾÷±×·¹À̵å
      • Á¤ºÎ·ÎºÎÅÍÀÇ ÅõÀÚ¿Í Áö¿ø Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • º¹ÀâÇÑ ÀýÂ÷¿Í ÀåºñÀÇ ³ôÀº ºñ¿ë
    • ±âȸ
      • ºñħ½À¼º ¹× Àúħ½À¼º ±â±â ¼ö¿ä Áõ°¡
      • ³ú ¸ð´ÏÅ͸µ ±â±âÀÇ Ä¡·á ¿ëµµÀÇ È®´ë
    • °úÁ¦
      • Áõ»ó¿¡ °üÇÑ Àνİú ÈÆ·ÃÀ» ¹ÞÀº Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : Á¦Ç°º°

  • ±âÁ¸ ±â±â
  • ¿þ¾î·¯ºí ±â±â

Á¦7Àå °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • Ŭ¸®´Ð
  • °¡Á¤Ä¡·á ȯ°æ
  • º´¿ø

Á¦8Àå ¾Æ¸Þ¸®Ä« °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾ç °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« °£Áú ¸ð´ÏÅ͸µ ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Cadwell Industries, Inc.
  • Compumedics Limited
  • Dragerwerk AG
  • Emfit Ltd.
  • Empatica Inc.
  • GE Healthcare
  • Koninklijke Philips NV
  • Masimo Corporation
  • Medpage Ltd.
  • Medtronic PLC
  • Natus Medical Incorporated by ArchiMed
  • Neurosoft Ltd.
  • Nihon Kohden Corporation
  • SAMi
  • St. Jude Medical Inc.
JHS 24.11.21

The Epilepsy Monitoring Device Market was valued at USD 552.77 million in 2023, expected to reach USD 593.61 million in 2024, and is projected to grow at a CAGR of 7.48%, to USD 915.96 million by 2030.

The epilepsy monitoring device market encompasses devices designed to detect, record, and analyze seizure activities in patients, enabling efficient diagnosis and management of epilepsy. These devices include EEG systems, wearables like smartwatches, and implantable devices that continuously monitor brain activity to provide timely alerts and data. The necessity arises from the crucial need to accurately monitor seizures for improved treatment plans and patient quality of life, combating challenges such as seizure unpredictability and misdiagnosis. Applications span hospitals, neurological centers, and homecare, with devices utilized by neurologists, caregivers, and patients themselves. Key growth factors include technological advancements in wireless communications and AI-driven analytics, alongside increased prevalence of neurological disorders and rising healthcare awareness. Furthermore, the integration of IoT in healthcare and growing demand for minimally invasive and non-invasive devices are opening new avenues. Opportunities for market growth lie in expanding telehealth services, developing more personalized, user-friendly devices, and enhancing diagnostic accuracy with advanced AI algorithms. Companies can capitalize by forming strategic partnerships for data sharing and accelerating FDA approvals. However, obstacles such as high device costs, regulatory challenges, and data privacy concerns pose significant barriers. Moreover, the lack of skilled professionals to interpret complex data remains a hurdle. There is potential in innovating compact, wearable devices with long battery life and high accuracy in seizure prediction and classification, as well as exploring blockchain for secure data management. Collaborative research and consistent feedback loops with end-users could also provide pivotal insights. The market is dynamic, with rapid technological progression but heavily competitive, requiring businesses to remain agile and customer-focused. Importantly, fostering trust through stringent data security measures and transparent patient communications will be fundamental in sustaining market reputation and growth.

KEY MARKET STATISTICS
Base Year [2023] USD 552.77 million
Estimated Year [2024] USD 593.61 million
Forecast Year [2030] USD 915.96 million
CAGR (%) 7.48%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Epilepsy Monitoring Device Market

The Epilepsy Monitoring Device Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence and prevalence of neurological disorders
    • Regular upgradations in technology for epilepsy monitoring devices
    • Rising investment and support from the government
  • Market Restraints
    • High cost of complex procedures and devices
  • Market Opportunities
    • Increasing demand for non-invasive and minimally invasive devices
    • Expanding therapeutic applications of brain monitoring devices
  • Market Challenges
    • Lack of awareness about symptoms and trained professionals

Porter's Five Forces: A Strategic Tool for Navigating the Epilepsy Monitoring Device Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Epilepsy Monitoring Device Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Epilepsy Monitoring Device Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Epilepsy Monitoring Device Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Epilepsy Monitoring Device Market

A detailed market share analysis in the Epilepsy Monitoring Device Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Epilepsy Monitoring Device Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Epilepsy Monitoring Device Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Epilepsy Monitoring Device Market

A strategic analysis of the Epilepsy Monitoring Device Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Epilepsy Monitoring Device Market, highlighting leading vendors and their innovative profiles. These include Cadwell Industries, Inc., Compumedics Limited, Dragerwerk AG, Emfit Ltd., Empatica Inc., GE Healthcare, Koninklijke Philips N.V., Masimo Corporation, Medpage Ltd., Medtronic PLC, Natus Medical Incorporated by ArchiMed, Neurosoft Ltd., Nihon Kohden Corporation, SAMi, and St. Jude Medical Inc..

Market Segmentation & Coverage

This research report categorizes the Epilepsy Monitoring Device Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Conventional Devices and Wearable Devices.
  • Based on End User, market is studied across Clinics, Home Care Settings, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence and prevalence of neurological disorders
      • 5.1.1.2. Regular upgradations in technology for epilepsy monitoring devices
      • 5.1.1.3. Rising investment and support from the government
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of complex procedures and devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing demand for non-invasive and minimally invasive devices
      • 5.1.3.2. Expanding therapeutic applications of brain monitoring devices
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about symptoms and trained professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Epilepsy Monitoring Device Market, by Product

  • 6.1. Introduction
  • 6.2. Conventional Devices
  • 6.3. Wearable Devices

7. Epilepsy Monitoring Device Market, by End User

  • 7.1. Introduction
  • 7.2. Clinics
  • 7.3. Home Care Settings
  • 7.4. Hospitals

8. Americas Epilepsy Monitoring Device Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Epilepsy Monitoring Device Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Epilepsy Monitoring Device Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cadwell Industries, Inc.
  • 2. Compumedics Limited
  • 3. Dragerwerk AG
  • 4. Emfit Ltd.
  • 5. Empatica Inc.
  • 6. GE Healthcare
  • 7. Koninklijke Philips N.V.
  • 8. Masimo Corporation
  • 9. Medpage Ltd.
  • 10. Medtronic PLC
  • 11. Natus Medical Incorporated by ArchiMed
  • 12. Neurosoft Ltd.
  • 13. Nihon Kohden Corporation
  • 14. SAMi
  • 15. St. Jude Medical Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦